Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123840983 | 12384098 | 3 | F | 20150913 | 20160902 | 20160519 | 20160909 | PER | US-ASTRAZENECA-2016SE51431 | ASTRAZENECA | 15201.00 | DY | F | Y | 129.00000 | KG | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123840983 | 12384098 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 50.4 | MG | U | U | 19726 | 3.6 | MG | IMPLANT | /month | |||
| 123840983 | 12384098 | 2 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Oral | 0 | TABLET | ||||||||||
| 123840983 | 12384098 | 3 | SS | SOLIFENACIN | SOLIFENACIN | 1 | Oral | 950 | MG | U | U | 0 | 5 | MG | TABLET | QD | |||
| 123840983 | 12384098 | 4 | SS | OXYBUTYNIN | OXYBUTYNIN | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 123840983 | 12384098 | 5 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 123840983 | 12384098 | 6 | C | MOTRIN | IBUPROFEN | 1 | 800.0MG UNKNOWN | 0 | 800 | MG | TABLET | ||||||||
| 123840983 | 12384098 | 7 | C | VIGAMOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 0.5% UNKNOWN | 0 | .5 | PCT | |||||||||
| 123840983 | 12384098 | 8 | C | NOLVADEX | TAMOXIFEN CITRATE | 1 | 20.0MG UNKNOWN | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123840983 | 12384098 | 1 | Breast cancer |
| 123840983 | 12384098 | 2 | Breast cancer female |
| 123840983 | 12384098 | 3 | Hypertonic bladder |
| 123840983 | 12384098 | 4 | Hypertonic bladder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123840983 | 12384098 | OT |
| 123840983 | 12384098 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123840983 | 12384098 | Constipation | |
| 123840983 | 12384098 | Dry mouth | |
| 123840983 | 12384098 | Headache | |
| 123840983 | 12384098 | Hypertonic bladder | |
| 123840983 | 12384098 | Nausea | |
| 123840983 | 12384098 | Somnolence | |
| 123840983 | 12384098 | Uterine haemorrhage | |
| 123840983 | 12384098 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123840983 | 12384098 | 1 | 20141016 | 20151214 | 0 | |
| 123840983 | 12384098 | 3 | 20150831 | 20160307 | 0 | |
| 123840983 | 12384098 | 4 | 20160308 | 0 |